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UNIT A3.4Extra-Axial Tumors
Extra-axial tumors most commonly arise from the meninges, calvarium, or skull base.
Localization of a lesion as extra-axial or extra-cerebral in origin, has significant clinical
importance in terms of treatment planning and predicting prognosis. High-resolution
fat-suppressed imaging is crucial for specific evaluation of the skull base, and correlation
with computed tomography (CT) is often helpful in these cases. This unit presents the set
of magnetic resonance sequences used for imaging extra-axial tumors found in specific
locations; sequence modifications will be discussed where necessary. The sequences
described in this unit are based on the authors’ experience with a 1.5 T scanner (GE
Medical Systems), but can be expected to be equally applicable to other field strengths
and scanners from other manufacturers.
BASIC
PROTOCOL
RULE OUT (R/O) EXTRA-AXIAL TUMOR
Spin-echo and fast spin-echo imaging (sequences 1 to 4) essentially provide all of the
information needed to make an accurate diagnosis when evaluating for primary extra-axial
tumors. The fluid-attenuated inversion recovery (FLAIR) images (sequence 4) and
post-contrast T1-weighted images (sequence 5) are most sensitive for evaluating tumor
spread particularly along the subarachnoid space (leptomeninges; Singer et al., 1998).
Sequences 1 to 5 comprise the preferred protocol.
Table A3.4.1 presents equipment parameters for imaging brain tumors.
NOTE: Be sure that technologists and nurses have immediate access to any equipment
such as crash carts or oxygen that may be necessary in the event of an emergency. Contrast
reactions are rare, but the resources are necessary.
Materials
Intravenous contrast agent (e.g., Magnevist, Omniscan, Prohance)
Normal saline (0.9% NaCl), sterile
Set up patient and equipment
1. Interview (screen) the patient to ensure that he or she has no contraindications such
as cardiac pacemaker or other implants containing ferromagnetic materials. Also be
sure to find out if the patient has any health conditions that may require the presence
of specific emergency equipment during the scanning procedure, or necessitate any
other precautions.
Generally standard screening forms are used for all patients scanned in a magnetic
resonance system.
The presence of any ferromagnetic metals may be a health hazard to the patient when he
or she is inside the magnet, and will also affect the imaging. If in doubt as to the exact
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Table A3.4.1 Equipment Parameters for Imaging Brain Tumors
Coil Type Quadrature head coil
Gradient coil strength 25 mT/m (or whatever the system permits)
Cardiac gating No
Peripheral gating For safety only
Respiratory gating No
Respirator If required by patient
Oxygen If required by patient
Motion cushions No
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composition of the items, it is best to exclude patients with metal implants; see Shellock
(1996) for discussion of what implants may be safely scanned using magnetic resonance.
Patients may be accompanied into the magnet room by a friend or family member, who can
sit in the room during the scan and comfort the patient as needed. This companion must
be screened as well to ensure the absence of loose metal objects on the body or clothing.
2. If the procedure is a research protocol, have the patient sign any necessary consent
form.
3. Have the patient remove all jewelry and change into a gown to eliminate any metal
that might be found in clothing.
4. Have the patient wash off any mascara and other makeup to avoid local tissue heating
and image artifacts.
5. Inform the patient about what will occur during the procedure, what he or she will
experience in the magnet, and how to behave, including the following:
a. If earphones or headphones are used to protect the ears from the loud sounds
produced by the gradients, the patient will be asked to wear these, but will be able
to communicate with you at any time during the imaging.
b. The patient will be given a safety squeeze-bulb or similar equipment to request
assistance at any time (demonstrate how this works).
c. For good results the patient should not talk, and should avoid or minimize
swallowing or other movement, during each scan—i.e., as long as the banging
sounds continue. Between scans, talking and swallowing are allowed in most
cases, but should be avoided when comparative positional studies are being
performed; the patient will be informed when this is the case.
d. Nevertheless, the patient may call out at any time if he or she feels it necessary.
6. Have the patient lie in the supine position on the table. Setup all monitoring equipment
before or right after the patient lies down.
7. Center patient in the head coil at the region where key information is desired.
Constrain the head and neck to prevent motion. Generally, fix the patient’s head so
that the head is horizontal (not tilted) and the neck and head lie along the axis of the
patient table.
8. If needed, place a pillow or other support under the knees to make the patient more
comfortable.
9. Use the centering light to position the patient (centered on the nasion) and put him
or her into the center of the magnet.
Once this step has been performed, so long as the patient does not move on the table, the
table itself can be moved and then replaced in the same position as before without
jeopardizing the positioning of one scan relative to another.
10. If the patient is unable to hold still, provide an appropriate sedative.
Sequence 1: Localizer
11. Run sequence 1 according to Table A3.4.2.
Sequence 2: T1-weighted scan
12. Run sequence 2 according to Table A3.4.3.
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Table A3.4.3 Primary Clinical Imaging Parameters for Sequence 2
(T1-Weighted)
Patient position Supine
Scan type Spin echo
Imaging plane (orientation) Transverse
Central slice or volume center Laser light centered on nasion
Echo time (TE) 11 msec (or select “minimum
full” echo time)
Receiver bandwidth (RBW) 10 kHz
Repeat time (TR) 500 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 240 mm, 240 mm
Resolution (∆x, ∆y) 0.94 mm, 1.25 mm
Number of data points collected (Nx, Ny) 256, 192
Slice thickness (∆z) 5 mm
Number of slices 20 (or as many as needed to cover
the region of interest)
Slice gap 2.5 mm
Number of acquisitions (Nacq) 1
Swap read and phase encoding Yes
Saturation pulses Not applicable
Scan time ∼1 min, 36 sec
Table A3.4.2 Primary Clinical Imaging Parameters for Sequence 1 (Localizer;
T1-Weighted)
Patient position Supine
Scan type Spin echo
Imaging plane (orientation) Sagittal
Central slice or volume center Laser light centered on nasion
Echo time (TE) 11 msec (or select “minimum
full” echo time)
Receiver bandwidth (RBW) 10 kHz
Repeat time (TR) 500 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 240 mm, 240 mm
Resolution (∆x, ∆y) 0.94 mm, 1.25 mm
Number of data points collected (Nx, Ny) 256, 192
Slice thickness (∆z) 5 mm
Number of slices 20 (or as many as needed to cover
the region of interest)
Slice gap 2 mm
Number of acquisitions (Nacq) 1
Swap read and phase encoding No
Saturation pulses Not applicable
Scan time ∼1 min, 36 sec
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Sequence 3: T2-weighted scan
13. Run sequence 3 according to Table A3.4.4.
Sequence 4: Fluid-attenuated inversion recovery (FLAIR) scan
14. Run sequence 4 according to Table A3.4.5.
Sequence 5: Post-contrast imaging
15. Remove the patient from the scanner. Do not allow the patient to move on the table.
Establish an intravenous line from for injection of contrast agent. Attach this line
securely to the patient so that movement into or out of the magnet will not pull at the
patient’s arm. Move the patient back into the scanner.
It is preferable to insert the line prior to imaging and to leave the patient in the magnet
with no intervening motion between the scans run before contrast agent injection and those
run after injection.
16. Leaving the patient in the magnet, inject the contrast agent, flush the line with 10 ml
saline.
A dose of 0.1 mmol/kg of contrast agent is usually given.
A delay in scanning may actually be beneficial when evaluating for metastases, which is
one of the reasons we scan in multiple planes after intravenous contrast administration.
17. Acquire the post-contrast images using the same parameters as in sequence 2
(T1-weighted scan; Table A3.4.3).
In addition to the transverse plane, the coronal plane is routinely obtained, with the
following changes to the parameters in sequence 2: (a) flow compensation is on; (b) TE is
20 msec (prolonged due to flow compensation gradients); and (c) it is not necessary to
swap read and phase encoding directions. In patients requiring sedation and in all pediatric
patients, we also routinely obtain a third post-contrast plane of imaging (sagittal).
Table A3.4.4 Primary Clinical Imaging Parameters for Sequence 3
(T2-Weighted)
Patient position Supine
Scan type Fast spin echo
Imaging plane (orientation) Transverse
Central slice or volume center Laser light centered on nasion
Echo time (TE) 102 msec (effective)
Receiver Bandwidth (RBW) 16 kHz
Echo train length (ETL) 8
Repeat time (TR) 3600 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 240 mm, 240 mm
Resolution (∆x, ∆y) 0.94 mm, 1.25 mm
Number of data points collected (Nx, Ny) 256, 192
Slice thickness (∆z) 5 mm
Number of slices 20 (or as many as needed to cover
the region of interest)
Slice gap 2.5 mm
Number of acquisitions (Nacq) 1
Swap read and phase encoding Yes
Saturation pulses Not applicable
Scan time ∼1 min, 30 sec
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ALTERNATE
PROTOCOL 1
MENINGIOMA
The majority of meningiomas are found incidentally and are located in the supratentorial
compartment (along the falx or cerebral convexity). Sequences 1 to 5 (see Basic Protocol)
comprise the preferred protocol. The location of the lesion determines whether further
sequences should be obtained (i.e., if the tumor is adjacent to the orbit or internal auditory
canals, then additional sequences examining the specific region should be obtained). Not
uncommonly, meningiomas may be inseparable from the adjacent dural venous sinus and
the question arises whether or not the tumor has invaded the venous sinus. In these cases,
magnetic resonance venography (MRV) is useful to confirm whether or not the venous
sinus is patent (see Chapter A2 for evaluating the cerebral venous sinuses).
For procedure, see Basic Protocol.
ALTERNATE
PROTOCOL 2
NERVE SHEATH TUMORS—E.G., ACOUSTIC NEUROMA
Patients with nerve sheath tumors typically present with sensorineural hearing loss, arise
within the vestibular or acoustic portions of cranial nerve VIII, and are found within the
internal auditory canals. High-resolution noncontrast (sequence 6) and post-contrast
imaging with fat suppression (sequence 7) is essential to evaluate this region. Imaging of
the entire brain with pre-contrast (sequences 1, 3, and 4) and post-contrast sequences
(sequence 5; see Basic Protocol) is a standard component of the complete evaluation of
these patients.
Set up patient and equipment
1. Use the same equipment and perform the same patient setup as for the previous
method (see Basic Protocol, steps 1 to 10).
2. Run sequences 1, 3, and 4 in Basic Protocol.
Table A3.4.5 Primary Clinical Imaging Parameters for Sequence 4 (FLAIR)
Patient position Supine
Scan type Inversion-recovery fast-spin echo
Imaging plane (orientation) Transverse
Central slice or volume center Laser light centered on nasion
Echo time (TE) 120 msec (effective)
Receiver Bandwidth (RBW) 16 kHz
Echo train length (ETL) 8
Repeat time (TR) 10,000 msec
Inversion time (TI) 2200 msec
Flip angle (FA) 180°
Fields of view (FOVx, FOVy) 240 mm, 240 mm
Resolution (∆x, ∆y) 0.94 mm, 1.25 mm
Number of data points collected (Nx, Ny) 256, 192
Slice thickness (∆z) 5 mm
Number of slices 20 (or as many as needed to cover
the region of interest)
Slice gap 2.5 mm
Number of acquisitions (Nacq) 1
Swap read and phase encoding Yes
Saturation pulses Not applicable
Scan time ∼5 min
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Table A3.4.7 Primary Clinical Imaging Parameters for Sequence 7
(Post-Contrast T1-Weighted)
Patient position Supine
Scan type Spin echo
Imaging plane (orientation) Transverse and coronal
Central slice or volume center Laser light centered on nasion
Echo time (TE) 20 msec
Receiver Bandwidth (RBW) 10 kHz
Repeat time (TR) 500 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 180 mm, 180 mm
Resolution (∆x, ∆y) 0.70 mm, 0.94 mm
Number of data points collected (Nx, Ny) 256, 192
Slice thickness (∆z) 3 mm
Number of slices As many as needed to cover the
area of interest
Slice gap 0.5 mm
Number of acquisitions (Nacq) 3
Swap read and phase encoding Yes, when it is transverse
Saturation pulses None except fat
Fat suppression Yes
Scan time 5 min, 20 sec
Table A3.4.6 Primary Clinical Imaging Parameters for Sequence 6
(T2-Weighted)
Patient position Supine
Scan type Fast spin echo
Imaging plane (orientation) Transverse
Central slice or volume center Laser light centered on nasion
Echo time (TE) 102 msec (effective)
Receiver Bandwidth (RBW) 16 kHz
Echo train length (ETL) 16
Repeat time (TR) 4000 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 180 mm, 180 mm
Resolution (∆x, ∆y) 0.70 mm, 0.70 mm
Number of data points collected (Nx, Ny) 256, 256
Slice thickness (∆z) 3 mm
Number of slices As many as needed to cover entire
skull base
Slice gap 0.5 mm
Number of acquisitions (Nacq) 3
Swap read and phase encoding Yes
Saturation pulses None except fat
Fat suppression Yes
Scan time 3 min, 20 sec
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Sequence 6: High resolution T2-weighted scan
3. Run sequence 6 (high-resolution transverse T2-weighted images through the internal
auditory canals) according to Table A3.4.6. This sequence nicely depicts the VII and
VIII cranial nerve roots.
Sequence 7: High resolution T1-weighted scan (post-contrast)
4. Repeat steps 15 and 16 in the Basic Protocol.
5. Run sequence 7 according to Table A3.4.7. Following the administration of contrast,
obtain sequence 7 in both the transverse and coronal planes through the internal
auditory canals.
6. In addition, obtain transverse T1-weighted images (sequence 5, step 17 in the Basic
Protocol) through the entire brain.
ALTERNATE
PROTOCOL 3
PITUITARY/SELLA TURCICA MASSES
Pituitary/sella turcica lesions are best evaluated by dedicated high resolution imaging of
the sella in the sagittal and coronal planes. Non-contrast imaging including high resolution
sagittal T1-weighted localizer (sequence 8), coronal T1-weighted (sequence 9) and coronal
T2-weighted images (sequence 6, with orientation changed to coronal and with no swap
read and phase encoding directions) beautifully depict complicated anatomic regions.
Contrast enhanced images (sequence 9) are essential and may demonstrate small pituitary
lesions (microadenomas) not seen otherwise. Post-contrast imaging (sequence 5) of the
entire brain is always performed.
Set up patient and equipment
1. Use the same equipment and perform the same patient setup as for the previous
method (see Basic Protocol, steps 1 to 10).
Sequence 8: T1-weighted localizer
2. Run sequence 8 (high resolution sagittal T1-weighted localizer of the sella) according
to Table A3.4.8.
Table A3.4.8 Primary Clinical Imaging Parameters for Sequence 8
(T1-Weighted Localizer)
Patient position Supine
Scan type Spin echo
Imaging plane (orientation) Sagittal
Central slice or volume center Laser light centered on nasion
Echo time (TE) 20 msec
Receiver Bandwidth (RBW) 10 kHz
Repeat time (TR) 500 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 160 mm, 160 mm
Resolution (∆x, ∆y) 0.63 mm, 0.83 mm
Number of data points collected (Nx, Ny) 256, 192
Slice thickness (∆z) 3 mm
Number of slices 20
Slice gap 0
Number of acquisitions (Nacq) 3
Swap read and phase encoding No
Saturation pulses Not applicable
Slice series Interleaved
Scan time 5 min
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3. Run sequence 3 (transverse T2-weighted of the entire brain) in Basic Protocol.
Sequence 9: High resolution T1-weighted scan
4. Run sequence 9 (coronal images through the sella) according to Table A3.4.9.
Sequence 10: High resolution T2-weighted scan
5. Run sequence 6 (coronal T2-weighted images of the sella) based on Table A3.4.6.
6. Repeat steps 15 and 16 in the Basic Protocol.
7. Run sequence 9 (post-contrast coronal T1-weighted images through the sella) accord-
ing to Table A3.4.9.
8. Run sequence 5 (transverse images of the entire brain).
ALTERNATE
PROTOCOL 4
ARACHNOID CYST
Arachnoid cysts are benign, developmental anomalies of the subarachnoid space and
typically demonstrate signal characteristics identical to that of cerebrospinal fluid (CSF).
Occasionally, difficulties arise in differentiating an arachnoid cyst from an epidermoid
cyst. FLAIR images or diffusion-weighted images may be useful to identify slight
differences in signal intensity from that of CSF, which would indicate an epidermoid cyst,
rather than an arachnoid cyst.
Set up patient and equipment
1.  Follow steps 1 to 10 in the Basic Protocol and run sequences 1 to 4.
Sequence 11: Diffusion-weighted imaging (DWI)
Multislice single-shot spin echo echo-planar diffusion-weighted sequences are obtained
with two diffusion gradient pulses applied before and after the 180° pulse. The pulse
Table A3.4.9 Primary Clinical Imaging Parameters for Sequence 9
(T1-Weighted)
Patient position Supine
Scan type Spin echo
Imaging plane (orientation) Coronal
Central slice or volume center Laser light centered on nasion
Echo time (TE) 20 msec
Receiver Bandwidth (RBW) 10 kHz
Repeat time (TR) 500 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 180 mm, 180 mm
Resolution (∆x, ∆y) 0.70 mm, 0.94 mm
Number of data points collected (Nx, Ny) 256, 192
Slice thickness (∆z) 3 mm
Number of slices As many as needed to cover the
area of interest
Slice gap 0.5 mm
Number of acquisitions (Nacq) 3
Swap read and phase encoding No
Saturation pulses No
Fat suppression No
Scan time 5 min, 20 sec
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sequence first acquires a set of transverse T2-weighted images (Beneviste et al., 1992)
without the diffusion gradients (thus b = 0). The diffusion gradients are then applied
sequentially in three orthogonal axes in the directions of slice select, phase encoding, and
read gradients to generate a set of 3 orthogonal-axis diffusion-weighted echo-planar
images (EPI). The b-value (diffusion sensitivity) is 1000 sec/mm2. A set of isotropic
images are calculated and displayed.
2. Obtain the DWI using parameters in Table A3.4.10 (sequence 11) to demonstrate that
the lesion remains iso-intense to CSF.
3. Repeat steps 15 to 17 (sequence 5) in the Basic Protocol.
ALTERNATE
PROTOCOL 5
EPIDERMOID/DERMOID
Epidermoid and dermoid cysts are congenital lesions frequently found along the cerebel-
lopontine angle, supra- and para-sellar regions, and middle cranial fossa. Epidermoid
cysts appear similar, but not identical, in signal intensity to that of CSF and in the majority
of cases epidermoids may be differentiated from arachnoid cysts by MRI. Dermoid cysts
contain fat within them and fat suppressed images may be useful to confirm the contents
of this lesion.
Set up patient and equipment
1. Repeat steps 1 to 10 and run sequences 1 to 5 (Basic Protocol).
2. Obtain fat suppressed T1-weighted images (parameters in sequence 2) in the trans-
verse or sagittal plane.
Table A3.4.10 Primary Clinical Imaging Parameters for Sequence 11 (DWI)
Patient position Supine
Scan type Diffusion-weighted EPI-spin echo
Imaging plane (orientation) Transverse
Central slice or volume center Laser light centered on nasion
Echo time (TE) 125 msec
Repeat time (TR) 10,000 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 240 mm, 240 mm
Resolution (∆x, ∆y) 1.88 mm, 1.88 mm
Number of data points collected (Nx, Ny) 128, 128
Slice thickness (∆z) 5 mm
Number of slices 30 with the diffusion gradients in
3 orthogonal directions
Slice gap 0
Number of acquisitions (Nacq) 1
Swap read and phase encoding No (to decrease peripheral nerve
stimulation)
Read direction Left–right
Saturation pulses Not applicable
b-value 1000 sec/mm2
δ 31 msec
∆ 36.6 msec
Scan time ∼45 sec
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ALTERNATE
PROTOCOL 6
CHONDROSARCOMA/CHORDOMA
Primary skull base lesions such as chordoma and chondrosarcoma can be infiltrative and
spread to involve skull base foramina. The main purpose of imaging is to determine the
full extent of the lesion (i.e., cranial nerve or meningeal involvement). The entire brain
should always be imaged (sequences 1 to 5). Fat suppressed high-resolution imaging,
including T2-weighted images (sequence 6) and post-contrast T1-weighted images (se-
quence 9) is essential when evaluating tumor involvement of skull base structures.
Set up patient and equipment
1. Use the same equipment and perform the same patient setup as for the previous
method (see Basic Protocol, steps 1 to 10).
2. Run sequences 1 to 4 (Basic Protocol) to evaluate the entire brain.
3. For high-resolution imaging of the skull base, run sequence 6 according to Table
A3.4.6 (transverse T2-weighted images) and sequence 9 according to Table A3.4.9
(with imaging plane changed to transverse, and with read and phase encoding
directions swapped). The entire extent of the lesion must always be included.
4. Repeat steps 15 and 16 in Basic Protocol.
5. Run post-contrast T1-weighted scans in two planes (transverse and coronal) according
to Table A3.4.9 adding the fat suppression option.
6. Run sequence 5 (post-contrast T1-weighted scan of the entire brain, step 17) in the
transverse plane.
COMMENTARY
Background Information
MRI is the preferred imaging modality for
defining extra-axial tumors. Obtaining detailed
information regarding the entire extent of dis-
ease is critical to the determination of appropri-
ate treatment. High resolution computed to-
mography (CT) of the skull base is often an
integral part of the work-up of a skull-base
lesion. MRI provides superior contrast and is
essential for documenting meningeal disease
and spread along cranial nerves (see UNITS A7.1-
A7.4). Intravenous contrast is critical to help
predict the full extent of disease.
Critical Parameters and
Troubleshooting
Fluid attenuated inversion recovery
(FLAIR) or post-contrast T1-weighted images
provide the greatest sensitivity in detecting ex-
tra-axial spread of tumor to the meninges.
When evaluating the skull base, fat-suppressed
high-resolution imaging (including T2-
weighted and post-contrast T1-weighted im-
ages) is essential to clearly delineate the full
extent of disease. With a resolution of less than
1 mm in the read and phase encoding directions,
there is superb visualization of the fine intricate
structures of the skull base (i.e., foramina and
cranial nerves). Fat-suppressed T1-weighted
images are critical to evaluate for abnormal
enhancement of cranial nerves, since high sig-
nal intensity on the T1-weighted images from
fat found along the skull base or chemical-shift
artifact from fat-containing structures can ob-
scure enhancement of cranial nerves. Inhomo-
geneities in the magnetic field can result in
incomplete fat suppression or unintended sup-
pression of water.
Anticipated Results
The goal of imaging when evaluating for
extra-axial tumors is to accurately localize and
detect the full extent of disease. Magnetic reso-
nance imaging offers superb anatomical detail
and tissue characterization of lesions. Fat sup-
pressed high-resolution MR imaging is a key
component of the skull-base examination.
FLAIR images and post-contrast T1-weighted
images are most sensitive for detecting
subarachnoid space disease.
Time Considerations
The majority of these protocols should take
∼30 min to complete.
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